We are live on
!
Find out more
GCM
Glenview Capital Management Portfolio holdings
AUM
$5.49B
1-Year Est. Return
46.89%
This Fund
S&P 500
This Quarter
Est. Return
-4.16%
1 Year Est. Return
+46.89%
3 Year Est. Return
+94.27%
5 Year Est. Return
+129.04%
10 Year Est. Return
+529.98%
AUM
$5.51B
AUM Growth
-$532M
(-8.8%)
Cap. Flow
-$291M
Cap. Flow
% of AUM
-5.28%
Top 10 Holdings %
Top 10 Hldgs %
49.82%
Holding
72
New
7
Increased
15
Reduced
35
Closed
11
Avg Time Held Equity + Options
8.2
quarters
Top 10 Avg Time Held Equity + Options
5.5
quarters
Top 20 Avg Time Held Equity + Options
6.5
quarters
Avg Time Held Equity only
8.4
quarters
Top 10 Avg Time Held Equity only
5.5
quarters
Top 20 Avg Time Held Equity only
6.5
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Willis Towers Watson
WTW
|
+$185M |
| 2 |
Uber
UBER
|
+$86.2M |
| 3 |
Baxter International
BAX
|
+$78.9M |
| 4 |
Global Payments
GPN
|
+$71.1M |
| 5 |
McKesson
MCK
|
+$49.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tenet Healthcare
THC
|
+$141M |
| 2 |
Walgreens Boots Alliance
WBA
|
+$121M |
| 3 |
Amazon
AMZN
|
+$71M |
| 4 |
Paramount Global Class B
PARA
|
+$69.3M |
| 5 |
DXC Technology
DXC
|
+$61M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 59.93% |
| 2 | Technology | 10.06% |
| 3 | Industrials | 7.31% |
| 4 | Materials | 5.94% |
| 5 | Communication Services | 5.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Tenet Healthcare
THC
$21.5B
| $575M | 10.43% |
8,652,741
-1,992,579
| -19% | -$141M |
2013 Q2
33 quarters
|
|
2
Bausch Health
BHC
$2.2B
| $436M | 7.9% |
15,649,243
-688,306
| -4% | -$19.5M |
2018 Q3
12 quarters
|
|
|
3
McKesson
MCK
$112B
| $345M | 6.26% |
1,731,042
+248,972
| +17% | +$49.8M |
2016 Q4
19 quarters
|
|
4
Cigna
CI
$74.7B
| $265M | 4.8% |
1,322,827
+38,474
| +3% | +$8.37M |
2013 Q2
33 quarters
|
|
5
Cencora
COR
$63B
| $225M | 4.09% |
1,886,005
+166,689
| +10% | +$20M |
2018 Q1
14 quarters
|
|
|
6
Global Payments
GPN
$21.7B
| $211M | 3.82% |
1,336,257
+409,291
| +44% | +$71.1M |
2020 Q4
3 quarters
|
|
|
7
Willis Towers Watson
WTW
$27.6B
| $194M | 3.51% |
+832,798
| New | +$185M |
2021 Q3
0 quarters
|
|
|
8
DXC Technology
DXC
$2.04B
| $188M | 3.41% |
5,601,965
-1,611,364
| -22% | -$61M |
2017 Q2
17 quarters
|
|
|
9
Baxter International
BAX
$12.9B
| $174M | 3.16% |
2,167,722
+998,335
| +85% | +$78.9M |
2020 Q1
6 quarters
|
|
10
Alphabet (Google) Class A
GOOGL
$4.33T
| $134M | 2.44% |
1,005,240
-109,640
| -10% | -$14.9M |
2015 Q4
23 quarters
|
|
11
Takeda Pharmaceutical
TAK
$59.2B
| $133M | 2.41% |
8,102,119
-1,013,402
| -11% | -$17M |
2019 Q1
10 quarters
|
|
12
Centene
CNC
$34B
| $132M | 2.4% |
2,122,427
+101,460
| +5% | +$6.78M |
2021 Q2
1 quarter
|
|
13
HCA Healthcare
HCA
$99.8B
| $127M | 2.31% |
525,237
-141,698
| -21% | -$34.6M |
2013 Q2
33 quarters
|
|
14
Aptiv
APTV
$9.19B
| $123M | 2.22% |
823,467
+302,954
| +58% | +$47.2M |
2020 Q4
3 quarters
|
|
15
Universal Health Services
UHS
$10.6B
| $122M | 2.21% |
879,079
-130,377
| -13% | -$19.7M |
2016 Q3
20 quarters
|
|
16
Coca-Cola Europacific Partners
CCEP
$46.3B
| $121M | 2.2% |
2,194,816
-91,017
| -4% | -$5.41M |
2021 Q1
2 quarters
|
|
|
17
Uber
UBER
$146B
| $109M | 1.98% |
2,432,683
+1,972,091
| +428% | +$86.2M |
2021 Q2
1 quarter
|
|
|
18
DELISTED
Paramount Global Class B
PARA
| $105M | 1.91% |
2,667,822
-1,700,855
| -39% | -$69.3M |
2013 Q2
33 quarters
|
|
19
DuPont de Nemours
DD
$17.5B
| $104M | 1.88% |
1,212,865
+222,066
| +22% | +$20.6M |
2020 Q4
3 quarters
|
|
20
Corteva
CTVA
$8.91B
| $93.6M | 1.7% |
2,224,846
-5,622
| -0.3% | -$243K |
2019 Q4
7 quarters
|
|
21
Molina Healthcare
MOH
$10.9B
| $89.6M | 1.62% |
330,105
+32,686
| +11% | +$8.63M |
2020 Q1
6 quarters
|
|
22
Boston Scientific
BSX
$62.8B
| $89.5M | 1.62% |
2,063,297
-259,719
| -11% | -$11.5M |
2020 Q1
6 quarters
|
|
23
Brookdale Senior Living
BKD
$2.42B
| $84.8M | 1.54% |
13,454,840
-1,252,416
| -9% | -$8.94M |
2014 Q2
29 quarters
|
|
24
Myriad Genetics
MYGN
$390M
| $72.2M | 1.31% |
2,235,168
-240,912
| -10% | -$8M |
2019 Q3
8 quarters
|
|
25
FMC
FMC
$1.29B
| $70.7M | 1.28% |
772,099
-100,458
| -12% | -$9.91M |
2015 Q1
26 quarters
|
|
Similar funds
GCM
VCM
ACM
MC
SCM
NC
EI
AP
Glenview Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Glenview Capital Management held 72 positions worth $5.51B, down 8.8% from $6.05B the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Glenview Capital Management withdrew a net $291M in Q3 2021, closing 11 positions and reducing 35 holdings. Its most notable exit was Walgreens Boots Alliance, an estimated $121M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 60% of assets, down from 62% a quarter earlier, followed by Technology and Industrials.
Against the trend, Glenview Capital Management opened a new position in Willis Towers Watson worth $194M.
- Glenview Capital Management's largest Q3 2021 buy was Willis Towers Watson: 832,798 shares worth $194M.
- Glenview Capital Management added most to Uber in Q3 2021, an estimated $86.2M increase.
- Glenview Capital Management's biggest Q3 2021 reduction was Tenet Healthcare, cutting an estimated $141M.
- Glenview Capital Management fully exited Walgreens Boots Alliance in Q3 2021, selling an estimated $121M.
- Glenview Capital Management's ten largest holdings make up 50% of its $5.51B portfolio in Q3 2021.
- Glenview Capital Management opened 7 new positions and closed 11 in Q3 2021.
- Glenview Capital Management's portfolio value fell 8.8% quarter-over-quarter to $5.51B.
Based on Glenview Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.